Trial Profile
A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2009
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Breast cancer; Multiple myeloma; Prostate cancer
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 09 Oct 2009 New trial record